Discovering The Potential Drug Target and Biomarker Dbf4 (G10926)

Target Name: DBF4

NCBI ID: G10926

DBF4

Discovering The Potential Drug Target and Biomarker Dbf4

Dbf4, also known as DBF4 zinc finger and transcript variant 1, is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a key regulator of stem cell proliferation and has been shown to play a role in the development and progression of various diseases, including cancer.

Dbf4 is a zinc finger transcription factor that was discovered in the ENCODE database. It is characterized by the presence of a zinc finger domain and a unique open reading frame structure. The zinc finger domain is a common feature of transcription factors that is responsible for their ability to bind to specific DNA sequences. The open reading frame (ORF) of Dbf4 is the region of DNA that is involved in the transcription of gene products.

Dbf4 is expressed in a variety of tissues and cells, including stem cells, neurons, and tissues of the brain. It is highly expressed in the human placenta, which is a key organ that is involved in the development and maintenance of the nervous system. Dbf4 is also expressed in various cancer types, including breast, ovarian, and prostate cancer.

Dbf4 is involved in a variety of cellular processes that are important for cell growth, differentiation, and survival. It is a regulator of stem cell proliferation and has been shown to play a role in the development and progression of various diseases, including cancer. It is also involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs.

Dbf4 is a potential drug target because of its involvement in various cellular processes that are important for human health. It is also a biomarker because it can be used to diagnose and monitor various diseases, including cancer.

Dbf4 as a drug target

Dbf4 has been shown to be involved in a variety of cellular processes that are important for human health. One of the most well-studied functions of Dbf4 is its role in stem cell proliferation. Stem cells are a type of cell that have the ability to develop into any type of cell in the body. They are a key source of tissue repair and regeneration and are involved in the development and maintenance of the nervous system.

Studies have shown that Dbf4 plays a role in the regulation of stem cell proliferation by controlling the expression of genes that are involved in cell growth and differentiation. This is done by binding to specific DNA sequences and regulating the activity of various enzymes that are involved in the cellular processes that are necessary for stem cell growth and differentiation.

In addition to its role in stem cell proliferation, Dbf4 has also been shown to be involved in the regulation of cell adhesion. Cell adhesion is the process by which cells stick together to form tissues and organs. This is an important process that is necessary for the development and maintenance of tissues and organs, including the nervous system.

Dbf4 is involved in the regulation of cell adhesion by controlling the expression of genes that are involved in cell adhesion. This is done by binding to specific DNA sequences and regulating the activity of various enzymes that are involved in the cellular processes that are necessary for cell adhesion.

Dbf4 as a biomarker

Dbf4 has also been shown to be involved in the development and progression of various diseases, including cancer. This makes it an attractive potential biomarker for the diagnosis and monitoring of these diseases.

Studies have shown that Dbf4 is highly expressed in a variety of cancer types, including breast, ovarian, and prostate cancer. This suggests that it may be a useful biomarker for the diagnosis and monitoring of these diseases. In addition, the expression of Dbf4 has been shown to be associated with the development

Protein Name: DBF4 Zinc Finger

Functions: Regulatory subunit for CDC7 which activates its kinase activity thereby playing a central role in DNA replication and cell proliferation. Required for progression of S phase. The complex CDC7-DBF4A selectively phosphorylates MCM2 subunit at 'Ser-40' and 'Ser-53' and then is involved in regulating the initiation of DNA replication during cell cycle

The "DBF4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DBF4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets